Haematology Formative 24/01/20 Flashcards
1
Q
What is the characteristic genetic abnormality in Chronic Myeloid Leukaemia?
- t(15;17) ATRA gene
- t(9;22) Philadelphia chromosome
- t(8;21) AML/ETO gene
- t(8;14) cMYC oncogene
A
- t(9;22) Philadelphia chromosome
2
Q
What class of drug best describes Rituximab?
- Cytotoxic chemotherapy
- Disease-modifying therapy
- Monoclonal antibody
- Antibiotic
A
- Monoclonal antibody
3
Q
Which age group is characteristically affected by Hodgkin lymphoma?
- Children
- Teenagers and young adults
- Middle aged (40-60 yrs)
- Older aged (>60yrs)
A
- Teenagers and young adults
4
Q
How is myeloma bone disease usually assessed?
- Plain X-ray
- Clinical assessment
- Isotope bone scan
- PET scan
A
- Plain X-ray
5
Q
What is the correct mechanism of action for the anti-emetic drug Ondansetron?
- Peripheral D2 antagonist
- Central D2 antagonist
- Anti-cholinergic
- 5HT3 antagonist
A
- 5HT3 antagonist
6
Q
What is the commonest cause of microcytic anaemia?
- B12 deficiency
- Iron deficiency
- Haematologic malignancy
- Hereditary spherocytosis
A
- Iron deficiency
7
Q
In sickle cell anaemia what would you expect to see the reticulocyte count?
- Absent
- Low
- Normal
- Raised
A
- Raised
8
Q
Bacterial infection usually causes:
- Low lymphocytes
- Low neutrophils
- High lymphocytes
- High neutrophils
A
- High neutrophil count
9
Q
Which best outlines the approach to the management of a patient with suspected febrile neutropaenia?
- Encourage fluids and paracetamol
- Perform cultures and wait for results before starting antibiotics
- Perform cultures and start oral antibiotics
- Perform cultures and start broad spectrum iv antibiotics
A
- Perform cultures and start broad spectrum iv antibiotics
10
Q
Malignant spinal cord compression usually presents with?
- Back pain, ataxia and sensory neuropathy
- Back pain, spastic paresis and a sensory level
- Perianal numbness and urinary incontinence
- Weak legs impaired joint position sense
A
- Back pain, spastic paresis and a sensory level
11
Q
How does Aspirin exert its antiplatelet effect?
- ADP receptor antagonist
- Inhibition of Cyclooxygenase enzyme
- Inhibition of Glycoprotein IIb-IIIa
- Inhibition of PAR4 receptor
A
- Inhibition of Cyclooxygenase enzyme